A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
单剂 SARS-CoV-2 FINLAY-FR-1A 疫苗可增强 COVID-19 康复者的中和反应，且安全性极佳：一项开放标签的 1 期临床试验
期刊:Lancet Regional Health-Americas
影响因子:7.6
doi:10.1016/j.lana.2021.100079
Chang-Monteagudo, Arturo; Ochoa-Azze, Rolando; Climent-Ruiz, Yanet; Macías-Abraham, Consuelo; Rodríguez-Noda, Laura; Valenzuela-Silva, Carmen; Sánchez-Ramírez, Belinda; Perez-Nicado, Rocmira; Hernández-García, Tays; Orosa-Vázquez, Ivette; Díaz-Hernández, Marianniz; García-García, María de Los Ángeles; Jerez-Barceló, Yanet; Triana-Marrero, Yenisey; Ruiz-Villegas, Laura; Rodríguez-Prieto, Luis Dairon; Puga-Gómez, Rinaldo; Guerra-Chaviano, Pedro Pablo; Zúñiga-Rosales, Yaíma; Marcheco-Teruel, Beatriz; Rodríguez-Acosta, Mireida; Noa-Romero, Enrique; Enríquez-Puertas, Juliet; Porto-González, Delia; Fernández-Medina, Olivia; Valdés-Zayas, Anet; Chen, Guang-Wu; Herrera-Martínez, Luís; Valdés-Balbín, Yury; García-Rivera, Dagmar; Verez-Bencomo, Vicente
